Beroni Group
Manufacturing · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
175 Pitt St L 16, Sydney, New South Wale...Phone Number
(214) 762-2888Website
www.beronigroup.comRevenue
<$5 MillionStock Symbol
BTGIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Beroni Group
Beroni Group is an Australia-based biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan.Explore more
Beroni Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Beroni Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Beroni Group had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Beroni Group has new funding data
Check out if Beroni Group is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Beroni Group
Beroni Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Beroni Group has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Beroni Group launches new products
Earning: See what the market has to say on Beroni Group recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Beroni Group
Find 3 more new buyers
Compare Similar Companies to Beroni Group
Compare insights from companies similar to Beroni Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Beroni Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Beroni Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Beroni Group.
Beroni Group Tech Stack
A closer look at the technologies used by Beroni Group
See more technologies
Beroni Group News & Media
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, announced that it has appointed Dr. John Chiplin as an independent director to Beroni’s Board of Directors effective April 1, 2022. Dr. Chiplin is an accomplished biotech execBeroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
NEW YORK and SYDNEY, Australia, March 23, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, announced today that the Company has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th froBeroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China
NEW YORK and SYDNEY, Australia, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, is pleased to announce today that it has signed a contract to build a new Research & Development (“R&D”) centre in the Zhuhai National High-Tech Industrial Development Zone inBeroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan
NEW YORK and SYDNEY, Australia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, announced that it has received part payment of a US$1.07M (JPY117.5M) order for its SARS-CoV-2 Antigen Test Kit from a Japanese pharmaceutical company based in Tokyo. Beroni ha
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Beroni Group
Sign Up For FreeTo access detailed company insights
Beroni Group is an Australia-based biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical prod... Read More
